Edelweiss MSCI I D W H 45 Index Fund IDCW
Summary Info
Fund Name
: Edelweiss Mutual Fund
Scheme Name
: Edelweiss MSCI I D W H 45 Index Fund IDCW
AMC
: Edelweiss Mutual Fund
Type
: Open
Category
: Equity - Index
Launch Date
: 06-Oct-2020
Fund Manager
: Bhavesh Jain
Net Assets (Rs. cr)
: 156.35
Edelweiss MSCI I D W H 45 Index Fund IDCW - Nav Details
Nav Date
: 26-Jun-2025
NAV [Rs.]
: 19.298
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Edelweiss MSCI I D W H 45 Index Fund IDCW- NAV Chart
Edelweiss MSCI I D W H 45 Index Fund IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.04 | 2.61 | -0.14 | -1.17 | 8.28 | 18.84 | - | 15.06 |
| Category Avg | 3.2 | 3.12 | 11.37 | 3.25 | 4.02 | 21.67 | 21 | 12.01 |
| Category Best | 7.25 | 13.33 | 43.37 | 32.41 | 25.95 | 32.92 | 33.27 | 40.41 |
| Category Worst | -0.14 | 0.07 | -0.14 | -10.08 | -9.99 | 16.8 | 17.32 | -15.34 |
Edelweiss MSCI I D W H 45 Index Fund IDCW- Latest Dividends
No Records Found
Edelweiss MSCI I D W H 45 Index Fund IDCW- Investment Details
Min. Investment(Rs.)
: 100
Increm.Investment(Rs.)
: 100
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.29 | 114548 | 19.21 |
| Equity | Max Healthcare | Healthcare Services | 6.68 | 92823 | 10.44 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.03 | 14258 | 9.42 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.87 | 62655 | 9.18 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.58 | 69715 | 8.72 |
| Equity | Apollo Hospitals | Healthcare Services | 5.29 | 12013 | 8.26 |
| Foreign Equity | ELI LILLY & CO | Pharmaceuticals | 4.86 | 1205 | 7.59 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 3.41 | 27227 | 5.33 |
| Foreign Equity | JOHNSON & JOHNSON | Pharmaceuticals | 3.05 | 3594 | 4.76 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 2.87 | 14138 | 4.48 |
| Foreign Equity | ABBVIE INC | Biotechnology | 2.68 | 2638 | 4.19 |
| Equity | Fortis Health. | Healthcare Services | 2.65 | 58570 | 4.13 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.33 | 14773 | 3.64 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.29 | 31195 | 3.58 |
| Foreign Equity | Novo Nordisk A/S | Pharmaceuticals & Biotechnology | 1.88 | 4808 | 2.93 |
| Foreign Equity | ABBOTT LABORATORIES | Health Care Equipment & Supplies | 1.87 | 2563 | 2.92 |
| Foreign Equity | NOVARTIS AG | Pharmaceuticals | 1.86 | 2942 | 2.91 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 1.79 | 30025 | 2.79 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 1.63 | 41835 | 2.55 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 1.63 | 4995 | 2.54 |
| Foreign Equity | INTUITIVE SURGICAL INC | Health Care Equipment & Supplies | 1.61 | 532 | 2.51 |
| Foreign Equity | MERCK & CO.INC | Pharmaceuticals | 1.59 | 3776 | 2.48 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 1.57 | 16840 | 2.45 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.52 | 16654 | 2.37 |
| Foreign Equity | AMGEN INC | Biotechnology | 1.26 | 802 | 1.97 |
| Foreign Equity | THERMO FISHER SCIENTIFIC INC | Life Sciences Tools & Services | 1.26 | 571 | 1.96 |
| Foreign Equity | GILEAD SCIENCES INC | Biotechnology | 1.10 | 1833 | 1.72 |
| Foreign Equity | STRYKER CORP | Health Care Equipment & Supplies | 1.07 | 512 | 1.67 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.07 | 49906 | 1.67 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 1.07 | 5055 | 1.66 |
| Foreign Equity | DANAHER CORP | Health Care Equipment & Supplies | 1.01 | 970 | 1.57 |
| Equity | Narayana Hrudaya | Healthcare Services | 0.95 | 8483 | 1.47 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 0.93 | 71205 | 1.46 |
| Foreign Equity | VERTEX PHARMACEUTICALS INC | Biotechnology | 0.93 | 384 | 1.45 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 0.90 | 8849 | 1.40 |
| Equity | Syngene Intl. | Healthcare Services | 0.89 | 21620 | 1.39 |
| Foreign Equity | MEDTRONIC PLC | Health Care Equipment & Supplies | 0.87 | 1914 | 1.35 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 0.84 | 5218 | 1.31 |
| Equity | Cohance Life | Pharmaceuticals & Biotechnology | 0.81 | 12153 | 1.27 |
| Equity | Global Health | Healthcare Services | 0.73 | 9617 | 1.14 |
| Foreign Equity | Regeneron Pharmaceuticals Inc | Pharmaceuticals | 0.43 | 161 | 0.67 |
| Foreign Equity | BECTON DICKINSON & CO | Health Care Equipment & Supplies | 0.41 | 433 | 0.63 |
| Foreign Equity | AGILENT TECHNOLOGIES INC | Life Sciences Tools & Services | 0.26 | 426 | 0.40 |
| Foreign Equity | IQVIA HOLDINGS INC | Life Sciences Tools & Services | 0.21 | 271 | 0.32 |
| Foreign Equity | ILLUMINA INC | Life Sciences Tools & Services | 0.11 | 237 | 0.16 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | C C I | -/- | 0.12 | 0 | 0.17 |
| Cash & Cash Equivalent | Accrued Interest | -/- | 3.64 | 0 | 5.70 |
| Net CA & Others | Net CA & Others | -/- | -0.07 | 0 | -0.07 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Edelweiss Mutual Fund
Incorporation Date:
23-Aug-2007
Total Assets Managed (Cr.):
1,65,727.64
Trustee/s:
Eedelweiss Trusteeship Co
Chairman:
Rujan Panjwani
CEO / MD:
Ms. Radhika Gupta
CIO:
NA
President:
NA
Director/s:
Sandeep Bhandarker, Mr.Bhavesh Jain
Compliance Officer/s:
Mr. Jehzeel Master
Investor Service Officer/s:
Mr. Abdulla Chaudhari
Fund Manager/s:
Bhavesh Jain
Auditors:
Nangia & CO LLP(Edelweiss, Walker Chandiok & Co LLP
OTHER INFORMATION
Registered Office:
Edelwiess House, Off.C.S.T. Road, Kalina, Mumbai - 400 098.
Contact Nos:
022 40979737
Fax:
022 40979878
Email:
Website:
